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Perspective on the Martini model
Siewert J. Marrink*a and D. Peter Tielemanb
The Martini model, a coarse-grained force field for biomolecular simulations, has found a broad range of
applications since its release a decade ago. Based on a building block principle, the model combines
speed and versatility while maintaining chemical specificity. Here we review the current state of the
model. We describe recent highlights as well as shortcomings, and our ideas on the further development
of the model.
Introduction
The use of coarse-grained (CG) models in a variety of simulation
techniques has proven to be a powerful tool to probe the spatial
and temporal evolution of systems on the microscale, beyond
what is feasible with traditional all-atom (AA) models. A large
diversity of coarse-graining approaches is available, ranging from
qualitative, often solvent-free, models to models including
chemical specificity. Models within the latter category are typically
parameterized based on comparison to atomistic simulations, a
so-called bottom-up or systematic multi-scale approach. They
are designed to match a set of specific target distributions from
the atomistic simulations, using iterative Boltzmann,1,2 force
matching,3,4 minimization of relative entropy,5 or conditional
reversible work6 approaches. For an extended overview of these
methods, the reader is referred to recent reviews.7–11
The Martini force field,12–14 developed by the groups of Marrink
and Tieleman, has also been derived in close connection with
atomistic models, especially for bonded interactions. However, the
philosophy of our coarse-graining approach is different. Instead of
focusing on an accurate reproduction of structural details at a
particular state point for a specific system, we aim for a broader
range of applications without the need to reparameterize themodel
each time. We follow a top-down approach by extensive calibration
of the non-bonded interactions of the chemical building blocks
against experimental data, in particular thermodynamic data such
as oil/water partitioning coefficients. Processes such as lipid
self-assembly, peptide–membrane binding, and protein–protein
recognition depend critically on the degree to which the con-
stituents partition between polar and non-polar environments.
The overall aim of our coarse-graining approach is to provide a
simple model that is computationally fast and easy to use, yet
flexible enough to be applicable to a large range of biomolecular
systems. Example input files for many systems can be downloaded
from http://cgmartini.nl. The first version of the CG force field, with
parameters for lipids only, was published by the Marrink group in
2004. The name ‘Martini’ for the force field was coined in 2007 with
the release of version 2.0 for lipids.13 The subsequent extension to
peptides and proteins14 was released as version 2.1, with recent
improvements to version 2.2, the current version.15
Although the Martini model was originally developed for use
with the GROMACS software suite,16 the general form of the
potential energy functions has allowed other groups to implement
the Martini model into other major simulation packages such as
NAMD,17 GROMOS18 and Desmond.19 Note that the groups of
Schulten17 and Sansom20 have developed CG protein force fields
compatible with the Martini lipid force field, but diﬀerent from
the Martini protein force field.
In this perspective we describe the current state of the
Martini model. We highlight its applications, carefully consider
its shortcomings, and sketch the road ahead. The rest of this
perspective is organized as follows. Below we describe the design
principles of the Martini model, and provide a comprehensive
overview of the field of applications. Subsequently, the limitations
of the model are described. An extensive outlook section ends
this paper.
Design principles of the Martini model
Mapping
The Martini model is based on a four-to-one mapping, i.e., on
average four heavy atoms plus associated hydrogens are represented
by a single interaction centre. The four-to-one mapping was
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chosen as an optimum between computational eﬃciency on
the one hand and chemical representability on the other hand.
Mapping of water is consistent with this choice, as four real
water molecules are mapped to a CG water bead. Ions are
represented by a single CG bead, which represents both the ion
and its first hydration shell. To represent the geometry of small
ring-like fragments or molecules (e.g., benzene, cholesterol, and
several of the amino acids), the general four-to-one mapping
approach is too coarse. Ring-like molecules are therefore mapped
with a higher resolution of up to two non-hydrogen atoms to
one Martini particle. The Martini mapping of major classes of
(bio)molecules is shown in Fig. 1.
Based on the chemical nature of the underlying structure,
the CG beads are assigned a specific particle type with more or
less polar character. The Martini model has four main types of
particle: polar (P), non-polar (N), apolar (C), and charged (Q).
Within each type, subtypes are distinguished either by a letter
denoting the hydrogen-bonding capabilities (d = donor, a =
acceptor, da = both, 0 = none) or by a number indicating the
degree of polarity (from 1 = low polarity to 5 = high polarity),
giving a total of 18 particle types or ‘building blocks’.
Non-bonded interactions
Non-bonded interactions are described by a Lennard-Jones (LJ)
12-6 potential. The strength of the interaction, determined by
the value of the LJ well-depth eij, depends on the interacting
particle types i,j. The value of e ranges from eij = 5.6 kJ mol
1 for
interactions between strongly polar groups to eij = 2.0 kJ mol
1
for interactions between polar and apolar groups, mimicking the
hydrophobic eﬀect. The eﬀective size of the particles is governed
by the LJ parameter s = 0.47 nm for all normal particle types. For
the special class of particles in ring-like molecules, slightly
reduced parameters are defined to model ring–ring interactions:
s = 0.43 nm, and eij is scaled to 75% of the standard value. The
full interaction matrix can be found in the original publication.13
In addition to the LJ interaction, charged groups (type Q) bear a
charge e and interact via a Coulombic energy function.
Coulombic interactions are screened implicitly with a relative
dielectric constant erel = 15 to account for the reduced set of
partial charges and resulting dipoles that occur in an atomistic
force field. Note that the non-bonded potential energy functions
are used in a shifted form. The non-bonded interactions are cut
off at a distance rcut = 1.2 nm. The LJ potential is shifted from
rshift = 0.9 nm to rcut. The electrostatic potential is shifted from
rshift = 0.0 nm to rcut. Shifting of the electrostatic potential
in this manner mimics the effect of a distance-dependent
screening. To alleviate some of the limitations of the implicit
screening of electrostatic interactions caused primarily by a
water model without charges or dipole, polarizable water
models were also recently introduced for use with Martini.21,22
With these models a much lower dielectric constant is used
because of the increased explicit screening (erel = 2.5 for the
Martini polarizable water model,21 erel = 1.3 for the Big Multipole
Water (BMW) model22).
The non-bonded interactions of the Martini model have been
parameterized based on a systematic comparison to experimental
thermodynamic data. Specifically, the free energy of hydration,
the free energy of vaporization, and the partitioning free energies
between water and a number of organic phases were calculated
for each of the 18 diﬀerent CG particle types. Martini reproduces
the correct trend in free energies of hydration and vaporization.
However, the actual values are systematically too high, implying
that the CG condensed phase is not as stable with respect to the
vapour phase as it should be. The same is true with respect
to the solid phase. This is a known consequence of using a
LJ 12-6 interaction potential, which has a limited fluid range
(see ‘Limitation’ section below). As long as its applications are
aimed at studying the condensed phase and not at reproducing
gas/fluid or solid/fluid coexistence regions, the most important
thermodynamic property is the partitioning free energy. Impor-
tantly, the water/oil partitioning behaviour of a wide variety of
compounds can be accurately reproduced with the current
version of Martini.
Bonded interactions
Bonded interactions are described by a standard set of potential
energy functions common in classical force fields, including
harmonic bond and angle potentials, and multimodal dihedral
potentials. Proper dihedrals are primarily used to impose secondary
structure on the peptide backbone. Improper dihedrals are mainly
used to prevent out-of-plane distortions of planar groups. LJ
interactions between nearest neighbours are excluded.
To parameterize the bonded interactions, we use structural
data either directly derived from the underlying atomistic
geometry (such as bond lengths of rigid structures) or obtained
from comparison to atomistic simulations. In the latter proce-
dure, the higher resolution simulations are first converted into a
‘‘mapped’’ CG (MCG) simulation by identifying the centre of
mass of the corresponding atoms as the MCG bead. Second, the
distribution functions are calculated for the mapped simulation
and compared to those obtained from a true CG simulation.
Fig. 1 Martini mapping examples of selected molecules. (A) Standard water particle
representing four water molecules. (B) Polarizable water molecule with embedded
charges. (C) DMPC lipid. (D) Polysaccharide fragment. (E) Peptide. (F) DNA fragment.
(G) Polystyrene fragment. (H) Fullerene molecule. In all cases Martini CG beads are
shown as cyan transparent beads overlaying the atomistic structure.
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Subsequently the CG parameters are systematically changed in
an iterative way until satisfactory overlap of the distribution
functions is obtained.
For proteins, the PDB databank has been used as an additional
source of atomistic reference geometries. Based on MCG distribu-
tions from the PDB, bonds, angles, and dihedral interactions were
optimized. Importantly, the bonded parameters depend on the
sequence, and are used to stabilize the secondary structure
elements of the protein; the lack of directional hydrogen bonds
prevents realistic folding at the Martini level of coarse-graining.
On top of this, an elastic network can be used to further constrain
the protein close to a particular, e.g. native, state. The elastic
network approach, named ElNeDyn,23 has been optimized with
respect to atomistic reference simulations.
Simulation parameters
The force field terms are coupled to the simulation algorithms
Martini was parameterized for, although there is some flexibility
in this regard. Key parameters include the timestep, neighbour
list update frequency, cut-oﬀ radii for the nonbonded potentials,
and the exact form of the switch function. Martini simulations
generally are stable with timesteps of up to 40 fs or 20 fs in the
presence of rings such as in cholesterol or proteins. Lower
values than 20 fs we consider an ineﬃcient use of computer
time as errors in the model will strongly dominate errors due to
numerical integration time steps.24 Energy conservation also
depends strongly on the use of neighbour lists, but the implementa-
tion of these lists diﬀers in diﬀerent software and for GROMACS in
diﬀerent versions. More frequent updates or the use of large buﬀer
zones removes errors associated with neighbour lists but come
at a computational cost as well. Martini is parameterized with a
switch function that reduces both LJ and Coulomb interactions
to zero at 1.2 nm. The form of this function together with the
accurate calculation of temperature turned out to be important
in implementing Martini in other software as errors may lead to
more serious temperature artefacts.25
Validation
Currently, the Martini force field provides parameters for a
variety of biomolecules, including many diﬀerent lipids,12,26–28
sterols,13,29 peptides and proteins,14,20,30 sugars,31,32 polymers,33–36
nanoparticles,37–39 dendrimers,40,41 and more. This family of
Martini molecules is constructed using the building block
principle, i.e. mapping the underlying chemical structure to
the corresponding flavor of CG particle types, and stringing
them together to reproduce the overall topology of the target
molecule. The basic assumption underlying Martini is that the
carefully parameterized properties of the individual beads are
transferable to the molecule as a whole. This basic assumption
requires validation, which may come either from comparing to
more detailed atomistic simulations or to experimental data.
Recent validation examples of the first category are: partitioning of
amino acid side chain analogues (SCAs) across the membrane,
which shows profiles matched to within 1–2 kT for most SCAs;42
dimerization of SCAs in solvents of different polarities, reproducing
most atomistic dimerization free energies to within 1 kT;43 and
the potential of mean force (PMF) between a pair of fullerenes
in different solvents, reproducing the atomistic profiles.39
Examples of validation with respect to experimental data are:
the area per lipid, typically reproduced to within 0.1–0.2 nm2 or
experimental accuracy for many types of lipid membranes;12,13
the ternary phase behaviour of lipid mixtures, showing phase
diagrams in semi-quantitative agreement;44 the relative binding
free energy of a systematic series of pentapeptides to the water/
lipid interface,45 consistent with the experimental hydrophobicity
scale derived from these peptides; dimerization free energies of
transmembrane (TM) helices within the range of experimental
values from FRET data;46 2H-NMR quadrupolar splittings of
WALP peptides,47 reproduced to a better extent than atomistic
simulations; and the structure of the glycophorin A dimer,48
compared to NMR data.
Many more critical tests have been performed in several of
the papers listed below in the Application section. Sometimes it
turns out that the set of standard Martini beads is not suﬃcient
to reproduce the desired accuracy, and further optimizations
are made. One of the advantages of Martini is its limited set of
parameters, which makes it relatively easy to adjust or optimize
the interactions. We quote the original characterization of the
Martini model:13 ‘‘how a few simple ingredients (read: chemical
building blocks) can be endlessly varied to create a complex
palette of taste’’. Cheers.
Martini based applications
The first applications of the Martini model, dating back
10 years, concerned the self-assembly49 and fusogenicity50 of
small lipid vesicles. Since these first studies, the list of applications
has grown dramatically, reflecting the flexibility and transferability
underlying our coarse-graining protocol. Currently, applications
can be grouped as: characterization of lipid membrane properties;
lipid polymorphism; protein–lipid interplay; membrane protein
oligomerization; self-assembly of soluble peptides and proteins;
protein conformational changes; binding and pore-formation
in membranes by membrane active peptides; design of drug
and gene delivery systems; structure and dynamics of lipo-
protein particles; membrane fusion; compression and expansion
of monolayers; self-assembly of surfactants; characterization of
carbohydrate based systems; structure and dynamics of polymers;
and interaction of nanoparticles with membranes. From this
overview it is apparent that lipid membranes are central in
many applications. Given the origin of the Martini force field
for simulations of lipid systems this is not surprising. Below we
discuss the main application areas to date.
Lipid membrane characterization
Although simple lipid membranes can be modelled at the fully
atomistic level, Martini oﬀers three significant advantages
given the current state of atomistic simulations: (i) the use of
a CG model allows many independent simulations in which state
conditions are systematically varied, e.g. the in silico design of robust
membranes,51 tethered or supportedmembranes,52–54 or correlating
lipid type and membrane properties;55,56 (ii) direct, unbiased,
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sampling of rare processes becomes possible, such as lipid flip–
flop and lipid desorption,57,58 deformation of asymmetric
membranes,59–62 or the membrane binding and permeation
of drugs and amphiphiles;63–67 and (iii) the Martini model
allows simulations requiring large system sizes, e.g. modelling
of lipid vesicles49,68–73 and calculation of membrane bending
moduli74–77 and viscosity.78 As an example of the latter category,
Baoukina et al.79 simulated the formation of membrane tethers
(Fig. 2A), mimicking micropipette aspiration experiments. The
largest systems studied contained close to 4 000 000 CG particles,
making it one of the biggest Martini-based simulations so far.
Lipid polymorphism
Another important area of applications of the Martini model is
lipid phase behaviour, requiring both large systems due to the
collective nature of phase transitions and long simulation times
to observe the critical nucleation events. Examples include the
formation of gel phases80–86 and inverted hexagonal26,87–89 and
cubic phases,90,91 or transitions between micelles, bicelles, and
vesicles.28 A snapshot of an inverted cubic phase stabilized by
fusion peptides, obtained by Fuhrmans and Marrink91 using a
self-assembly approach, is shown in Fig. 2B. An important
breakthrough in our ability to model realistic, heterogeneous,
membranes was reported by Risselada and Marrink,44 who
simulated the spontaneous formation of liquid-ordered (Lo)
and liquid-disordered (Ld) domains in ternary mixtures of
saturated and unsaturated lipids together with cholesterol.
Probing the structural and dynamical properties of these fluid
domains has received a lot of attention, as it is presumably
linked to the formation of lipid nano-domains (‘‘rafts’’) in real
cells. Follow up studies have further explored the properties of
these domains in a number of ways, including: systematic
evaluation of composition,29,92–96 studying partitioning of lipids
and amphiphiles at Ld/Lo domain boundaries,97,98 probing
conditions for domain registration,99 observing sorting anomalies
of domains under stress,100 looking into the effect of immobiliza-
tion on domain formation,101 and analysis of raft dynamics.102–105
A recent review by Bennett and Tieleman covers in more detail
simulations of membrane domains and membrane asymmetry,
including many Martini simulations.106
Membrane protein–lipid interplay
Martini has proven to be very useful to probe protein–lipid
interactions of membrane embedded proteins. Recent applica-
tions can be broadly classified into six categories: (i) predicting
binding modes of proteins to membranes as well as membrane
adaptation around proteins, as exemplified by many simula-
tions of a variety of peptides46,107–112 and proteins.113–118 These
kinds of simulations can be efficiently done in high-throughput
mode using a self-assembly approach pioneered by Sansom
and coworkers.119,120 3D stress profiles around membrane
proteins121–123 have been resolved using Martini as well;
(ii) simulating protein sorting, notably the propensity of TM
peptides and membrane proteins to partition in either Ld or Lo
domains.124–129 Domanski et al.,129 for instance, modelled the
sorting of TM model peptides (the synthetic WALP peptides)
under crowding conditions. They found that, at lipid/protein
ratios characteristic of real membranes, the peptides induced
Ld/Lo domain segregation (Fig. 3C). Unravelling the complicated
dynamics of membrane proteins in homogeneous membranes is
a related area of interest;129–134 (iii) identifying specific lipid
binding sites on membrane proteins is a rapidly growing area.
Current examples include the enrichment of short-tail lipids
around OmpA,135 phosphatidylinositolphosphate (PIP) binding
to the pleckstrin homology domain136 and to inwardly rectifying
potassium (Kir) channels,137,138 cardiolipin binding to mito-
chondrial creatine kinase (MtCK),139 cytochrome c oxidase,140
and cytochrome bc1,141 cholesterol binding to the serotonin (1A)
receptor,142 enrichment of anionic lipids at the gap junction
hemichannel connexion-26,143 at potassium channels KcsA
and chimeric KcsA-Kv1.3,144 and at TM and juxtamembrane
Fig. 2 Large scale membrane remodelling. (A) Pulling of a membrane tether
from a planar lipid bilayer.79 Lipid head groups are coloured grey, lipid tails green.
The tether is partly cut to view the inside. (B) Stabilization of an inverted cubic
phase by fusion peptides.91 Fusion peptides are depicted as red cylinders, the
water/lipid interface is rendered as a green surface. The space occupied by the
lipids is coloured black.
Fig. 3 Membrane protein sorting and clustering. (A) Formation of membrane
folds (cristae) by ATP synthase dimers148 (courtesy of W. Ku¨hlbrandt). Membrane
surface rendered blue, proteins in yellow. Adapted with permission from ref. 148.
Copyright (2012) National Academy of Sciences. (B) Aggregation of membrane
proteins due to hydrophobic mismatch152 (courtesy M. S. P. Sansom). Membrane
viewed from top in blue, with barrel proteins depicted yellow. Adapted with
permission from ref. 152. Copyright (2011) Elsevier. (C) Sorting of transmembrane
helices into liquid-disordered domains.129 TM helices in yellow, unsaturated lipids
red, saturated lipids blue, cholesterol grey with the white hydroxyl group.











































This journal is c The Royal Society of Chemistry 2013 Chem. Soc. Rev., 2013, 42, 6801--6822 6805
domains of cytokines,145 specific interactions of phosphatidic acid
(PA) and PIP2 with the actin capping protein (CP),146 and binding
of cholesteryl esters to cholesteryl ester transfer protein;147 (iv)
simulating protein mediated membrane remodelling, i.e. the defor-
mation of membranes under the action of proteins, is also suitable
for ‘Martinization’ as proven by an increasing number of applica-
tions. A fine example is the large-scale simulation of Davies et al.,148
probing the role of F1F0-ATP synthase dimers in shaping the
mitochondrial cristae. Based on these simulations, the authors
propose that the assembly of ATP synthase dimer rows is driven
by the reduction in the membrane elastic energy, rather than
by direct protein contacts, and that the dimer rows enable the
formation of highly curved ridges in mitochondrial cristae (Fig. 3A).
Other examples in the category of membrane remodelling are
simulations of the curvature field induced by a-synuclein,149
and the shaping of membranes by BAR domains.150 Studies on
(v) membrane-mediated protein clustering and (vi) gating are
described in sections below.
Membrane protein oligomerization
Many integral membrane proteins assemble in oligomeric
structures in biological membranes. The Martini force field
makes it possible to study these self-assembly processes at
near-atomic detail over time scales of micro- to milliseconds.
The first study on large scale protein assembly, by Periole
et al.,151 considered rhodopsin, a prototypical G-protein coupled
receptor (GPCR). Starting from random initial positions, the
proteins formed linear aggregates due to competition of non-
specific lipid mediated forces and specific sidechain–sidechain
interactions at the protein surface. This explained in detail
previous experimentally observed linear aggregates. An extensive
systematic study on aggregation of model membrane proteins,
modulated by hydrophobic mismatch, membrane curvature,
and protein class, was performed by Parton et al.152 An example
from this study is presented in Fig. 3B, showing clustering of
generalized b-barrel proteins under mild mismatch conditions.
Other examples of protein–protein self-assembly simulated with
Martini include the dimerization studies of glycophorin A,48,153
the repressor of primer protein,23 the c0-subunit of the ATP
synthase complex,154 TM WALP peptides,46,47,124,129 gramicidin
channels,155 the delta opioid receptor,156 TM domains of ErbB2
receptors157 and Fukutin-I,158 integrin TMhelix heterodimers,159,160
the integrin–talin complex,161,162 the cohesion-dockerin system,163
the TM domain of T cell receptor complex,164 the bacterial stress-
response peptide TisB165 and the serine receptor Tsr,166 as well
as tetramerization of the TM domain of the M2 channel167 and
modelling of caseinolytic peptidase B (ClpB) hexameric ring
structures.168 The fast sampling speed of Martini also allows
computation of the dimerization free energy of membrane
proteins; recent studies of GPCRs169,170 and OmpF171 reveal
specific, favorable, association interfaces.
Self-assembly of soluble peptides and proteins
In addition to membrane proteins, aggregation of soluble
proteins is a potentially large field of Martini applications.
So far, however, self-assembly simulations have been restricted
mainly to small peptides. A number of these studies deal with
dipeptides. In a very nice high-throughput study by Frederix
et al.,172 the Martini force field was used to screen all 400
dipeptide combinations and predict their ability to aggregate as
a potential precursor to their self-assembly. Systems that
showed strong aggregation tendencies were selected for longer
simulations in which supramolecular structures were formed
consistent with known aggregation states of dipeptides reported
in the literature (Fig. 4A). Related studies show self-assembly of
diphenylalanine peptides into a range of morphologies,173 and of
N-(fluorenyl-9-methoxycarbonyl)-dialanine peptides into hydro-
gels.174 Aggregation of larger peptides has also been the subject
of a number of Martini studies. Lee et al.175 addressed the self-
assembly of peptide amphiphiles, composed of a 13-residue
hydrophilic peptide connected to a hydrophobic tail. In line
with experimental data, they observed spontaneous formation
of fibres (Fig. 4B). Likewise, self-assembly of amphiphilic
peptides into peptide-vesicles (‘‘peptosomes’’)176 or micelles177
has been simulated. A particular challenging case for CG
models such as Martini, which lack directional hydrogen
bonds, is the formation of amyloid fibrils. For a realistic
simulation of amyloid formation, a more detailed description
of the peptide backbone is probably required;178 more qualita-
tive studies, however, can be performed. For instance, Sorensen
et al.179 modelled the assembly of amylin (20–29) peptides, pre-
assembled into protofibril fragments. The protofibril fragments
were kept together with an elastic network using the ElNeDyn23
approach. The simulations pointed to an elongation growth
mechanism of the protofibrils into fibres (Fig. 4C). Another
example is the study on the effect of lipid concentration on the
aggregation propensity of the amyloidogenic peptide apolipo-
protein C-II (60–70).180 Martini studies of interactions between
soluble proteins are still limited, but do exist, for example on
the stability of the spider silk’s N-terminal protein domain181
and of keratin filaments,182 the stability of engineered nano-
fibres,183 the mechanical properties of protein filaments,184,185
Fig. 4 Self-assembled peptide aggregates. (A) Nanotube formed by diphenyl-
alanine peptides172 (courtesy of P. W. J. M. Frederix). Peptide backbone in red,
side chains grey, and water inside the tube blue. (B) Fibre formed by a peptide
amphiphile175 (courtesy of G. C. Schatz). IKVAV epitope, blue; rest of PA, grey. (C)
Fibre composed of amylin (20–29) peptide fragments.179 Phenylalanine side
chains, purple; other side chains, yellow; backbone, cyan.
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and dissociation of gas phase protein complexes.186,187 A
related application of the Martini model is protein adsorption
on solid supports188,189 or at fluid interfaces.190 Martini could
also be used to screen for protein–ligand interactions in
principle. Thus far, we are aware of one example, in which
peptide binding to the OppA transporter was studied.191
Conformational changes in proteins
Although secondary structure changes of proteins cannot be
modelled in Martini yet, changes in tertiary structure are
unrestricted and in principle realistic within the general
approximations underlying our CG model. A fine example is
the gating process of the mechano-sensitive channel of large
conductance (MscL). When the membrane is put under ten-
sion, MscL channels undergo significant conformational
changes in accordance with an iris-like expansion mechanism
and reach a conducting state on a microsecond timescale.192,193
The gating of an MscL channel embedded in a liposome has
been simulated in a large-scale study by Louhivuori et al.194
After putting the liposome under stress by adding excess water,
mimicking hypoosmotic shock conditions, the MscL channel
opened to release excess solvent (Fig. 5A). The energetics of the
gating process have been analysed in more detail elsewhere.195
Full closure of the channel has also been achieved in simula-
tions of the reversible gating of MscL by Ingolfsson et al.196
(Fig. 5B). Structural transitions of other channel proteins
that have been simulated with Martini include voltage-gated
potassium channels,197 the SecY channel,198 and Ca-ATPase.199
Furthermore, acyl carrier protein (ACP) substrate-shuttling
within the fatty acid synthase reaction chamber has been
modelled,200 providing valuable insight into the role of linkers
and crowding in the shuttling process. The dynamics of
membrane-bound and soluble cytochrome P450 has also been
studied, revealing correlations between opening and closing of
diﬀerent tunnels from the enzyme’s buried active site.201
Another study addresses collective motions of RNA polymerases
that might contribute significantly to the conformational transi-
tion between the open and closed states.202 A final example is a
Martini study on the dynamics of TM helices of bacterial chemo-
receptors, supporting a piston model of signalling.203
Peptide induced membrane permeabilization
Antimicrobial peptides (AMPs) are still in the spotlight as
potential new antibiotics essential to overcome bacterial resis-
tance to conventional antibiotics, while similar peptides are
studied as anti-cancer and anti-fungal agents as well as vehicles
for drug delivery. At a certain threshold concentration, AMPs
permeabilize the membrane, either by forming a discrete pore
or by disrupting the bilayer structure. Using the Martini model
it is in principle possible to simulate AMP induced membrane
poration. A first example was shown as validation example
of the protein force field.14 Magainin peptides stabilized a
toroidal pore with a structure similar to those seen with
atomistic models. In Martini simulations, spontaneous pore
formation typically has been observed only under rather favour-
able conditions, such as in very thin bilayers,204 at very high
peptide concentrations,205,206 or with highly asymmetric bilayers.207
Other attempts to simulate AMP-induced membrane poration
revealed potential problems with Martini, such as the formation
of dehydrated pores208,209 or membrane buckling,210,211 see the
section on ‘Limitations’ below. Stabilization of pores by human
islet amyloid polypeptides has also been investigated,212 as well as
pores stabilized by fusion peptides.90,91,213 Likewise, Martini allows
for systematic calculations of the binding and translocation free
energy of AMPs214,215 and other membrane active peptides such as
caveolin,216 but also in these cases the shortcoming of Martini in
modelling lipid-lined membrane pores has to be kept in mind. The
ability of AMPs in a surface bound state to cluster charged lipids
does not suﬀer from this problem, and is therefore expected to be a
real phenomenon well suited for Martini.217,218
Drug and gene delivery systems
Membranes pose a barrier for typical drug molecules and gene
fragments and hinder their use in practice. Therefore, design of
delivery vehicles that help these molecules to cross the cell
membrane is an active area of research in which Martini has
found a growing number of applications. A series of simulation
studies of polyamidoamine (PAMAM) dendrimers show these
Fig. 5 Proteins in action. (A) Gating of a mechanosensitive protein channel,
MscL, in a liposome under hypoosmotic shock.194 (B) Reversible gating of MscL in
a planar membrane196 (courtesy H. Ingolfsson). Upper panel shows snapshots of
the closed starting structure, the open structure under tension, and the closed
structure after tension has been released. Lower graphs shows the applied
surface tension (red) and water flux (black) as a function of time.
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nanoparticles are able to porate membranes.40,41 PAMAMs can
be functionalized to optimize drug loading.219 Other polymer-
based delivery systems that have been investigated using the
Martini model are poly(gamma-glutamyl-glutamate) paclitaxel
(PGG-PTX), a series of semiflexible polymer–drug constructs
varying in PTX loading fraction220–222 and ABA type triblock
copolymers.223 The design of self-assembling nanofibres
composed of amphiphilic peptide derivatives for delivery of
therapeutic peptides has also been addressed.224 Other examples of
Martini-based studies of drug-delivery systems include simulations
of encapsulation of propofol in quaternary ammonium palmitoyl
glycol chitosan micelles,225 investigation of the permeability of
lysolipid-incorporated liposomes for enhanced permeation of
anticancer drugs,226 and fusion of perfluorocarbon-based
nanoemulsions to target liposomes.227 Considering gene
delivery, the structure of lipoplexes (DNA–lipid complexes)
has been modelled.228 A recent large scale Martini application
by Leung et al.229 involves modelling of lipid nanoparticles
containing ionizable cationic lipids, enabling therapeutic appli-
cations of siRNA (Fig. 6A).
Lipoprotein particles
Low-density and high-density lipoproteins (LDL/HDL) transport
cholesterol in the bloodstream and play an important role in
the development of atherosclerosis. They consist of a mixture of
components including phospholipids, triglycerides, cholesterol,
and associated proteins. The Martini model has proven useful to
study the structure and dynamics of these particles, starting with
the self-assembly of model HDL by Shih et al.230 using the
Martini variant developed by the Schulten group. Subsequently,
the structure and dynamics of HDL231,232 with realistic size and
lipid composition have been modelled with standard Martini.
The interfacial tension and surface pressure of various lipid
droplets have also been investigated.233 A model for LDL was
also developed, by Murtola et al.,234 and consists of an ApoB-100
protein wrapped around a 20 nm thick lipid droplet (Fig. 6B).
The simulations reveal a complex distribution of the lipid
constituents in the particle, and point to biologically relevant
contacts between the surrounding protein and some of the core
molecules. Another type of lipoprotein particle is the complex
formed by Saposin A, a protein involved in lipid transfer.
Simulation studies show that the protein can solubilize various
phospholipids into small discs.235 Martini based simulations
have been helpful to reveal the molecular packing of artificial
lipoprotein particles, so-called nanodiscs, which are increasingly
used by experimentalists to characterize membrane proteins.
Examples are nanodiscs stabilized by amphipathic polymers
(amphipols)236 or engineered proteins.237
Membrane fusion
Membrane fusion was one of the very first applications of the
Martini model50 and is still a hot topic where simulation studies
can resolve details that are not easily probed experimentally.
Possible fusion pathways between lamellar membranes and
between vesicles are now quite well established,50,87,238,239 and
current eﬀorts are directed to calculate the energetics of the
various intermediates240–244 and to investigate the role of fusion
promoting molecules such as PEG.245 An important new direc-
tion is peptide and protein mediated fusion. Baoukina and
Tieleman246 simulated the fusion of small unilamellar vesicles
mediated by lung surfactant protein B (SP-B). They found SP-B
monomers capable of triggering fusion events, consistent with the
experimentally observed fusogenic effect of SP-B, by anchoring two
vesicles and facilitating the formation of a lipid bridge between the
proximal leaflets. Another recent example is the Martini simulation
of neuronal SNARE-mediated membrane fusion by Risselada
et al.247 (Fig. 7A). The simulations reveal that SNARE complexes
mediate membrane fusion in a cooperative and synchronized way,
requiring at least one single SNARE complex consistent with single-
molecule fluorescence studies. After fusion, the zipping of the
SNAREs extends into the membrane region, in agreement with
the recently resolved X-ray structure of the fully assembled state.
Force transduction of the SNARE protein synaptobrevin has
Fig. 6 Molecular view on nanoparticles. (A) Lipid nanoparticle used for gene
delivery,229 composed of ionisable lipids (yellow), cholesterol (pink), phospholipid
(grey; lipid polar moiety in cyan), PEG–lipid (violet) and 12 bp DNA (red). (B) Low
density lipoprotein particle234 (courtesy I. Vattulainen), consisting of a droplet of
lipids (blue), cholesterol (green), triglycerides (yellow), and cholesterylester
(brown), bound to lipoprotein ApoB-100. Adapted with permission from
ref. 229. Copyright (2012–2013) American Chemical Society.
Fig. 7 Examples of protein mediated fusion. (A) Fusion of vesicles induced by
SNARE proteins247 (courtesy H. J. Risselada). Lipids are coloured with orange
heads and grey tails, interior water in blue, and the SNARE complexes with yellow
TM helices and red/green/blue soluble parts. (B) Fusion of vesicles and mono-
layers mediated by lung surfactant protein SP-B258 (courtesy S. Baoukina). Lipids
are shown in grey with blue (vesicle) or purple (monolayer) heads, protein
backbone in red.
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also been looked into with Martini.248 Furthermore, wild-type
hemagglutinin (HA) influenza fusion peptides were shown to
stabilize a highly fusogenic pre-fusion structure, i.e. a peptide
bundle formed by four or more TM fusion peptides.213 Studies
onmutant peptides provided a rationale for experimentally observed
incomplete fusion pathways. Related studies also point to the ability
of HA fusion peptides to stabilize fusion intermediates.90,91 For a
recent review of simulations on fusion, including many Martini-
based works, see Markvoort and Marrink.249
Lipid monolayers
At polar–apolar interfaces, lipids form monolayers that reduce
the surface tension. Besides being of fundamental interest for
surface science, lipid monolayer collapse is crucial for main-
taining low surface tension at the gas-exchange interface in the
lungs during breathing. The Martini force field can be used to
study the behaviour of lipid monolayers in detail, both for pure
lipid systems and in combination with peptides and proteins.
Although quantitative reproduction of the pressure–area iso-
therms at low surface pressure remains challenging,250 the
model is well suited to study properties of monolayers in the
liquid-expanded and liquid-condensed phases,250,251 and to
study for instance the collapse of lipid monolayers at high
surface pressure.252 Mixed monolayers have also been studied,
e.g. to model the tear fluid lipid layer,253–255 or to study phase
transitions256 and phase coexistence,103,104 and the effect of the
presence of lung surfactant proteins.257 In a large scale study
Baoukina and Tieleman simulated fusion of lipid reservoirs to
monolayers mediated by lung surfactant protein SP-B.258 They
found SP-B induced establishment of a lipid-lined connection
similar to the hemifusion stalk (Fig. 7B) allowing lipid flow in a
surface-tension-dependent manner. These findings are in line
with existing hypotheses on SP-B activity in lung surfactant and
explain its molecular mechanism.
Surfactant self-assembly
The Martini force field is ideally suited to study formation of
micelles, as it enables simulations that are long enough to
equilibrate many surfactant solutions. However, the ability to
obtain an equilibrated micellar size distribution depends on
the type of surfactant; exchange of surfactants between
micelles, and fusion and fission of small micelles are only
observed for surfactants with a relatively high CMC. For
instance, in the first study on surfactants using the Martini
model, DPC (dodecyl-phosphatidylcholine) could be observed
to self-assemble into micelles, but convergence of the size dis-
tribution was very slow and not achieved on the sub-microsecond
time scale.12 Recent Martini simulation studies, involving acyl-
trimethylammonium chloride,259,260 dodecyltrimethylammonium
bromide (DTAB),73 cetyltrimethylammonium bromide (CTAB),261
sodium dodecyl sulphate (SDS),262 dihexanoyl-PC (DHPC),263
and pentaethylene glycol monododecyl ether (C12E5),264 how-
ever, achieve longer (multi-microsecond) simulation times and
approach equilibrium distributions. Sampling of interesting
phenomena, such as the sphere-to-rod transition,259,261,264
becomes possible. In a study comparing a number of surfactants,265
the Martini model reproduced experimental CMCs and aggre-
gation numbers for non-ionic surfactants reasonably well. The
temperature dependence of these properties, however, is not
correct. Reproducing the correct temperature dependence is a
known challenge for CG models in general (see ‘Limitation’
section below). Martini simulations of micelles can also be
used to provide starting structures for fine-grained models, as
shown in a recent study on lyso-phospholipids,266 and to
provide details on the absorption and desorption process of
non-ionic surfactants.267 Bicelles, composed of double tail and
single or short tail lipids, have also been the topic of a number
of studies.28,268,269
Carbohydrates
Carbohydrates (saccharides) constitute a fundamental class of
biomolecules and are present in a variety of emerging classes of
biomimetic materials. The large size of most polysaccharides
warrants the use of a coarse-grained model, yet the complexity
of carbohydrate physico-chemical properties makes this a
very challenging undertaking. Recently, common mono- and
disaccharides have been parameterized for Martini,31 providing
a basis for further carbohydrate modelling. Simulations of
glucose and trehalose interacting with a DPPC membrane show
suppression of gel phase formation,31 in agreement with the
cryoprotective properties of these sugars. Based on the Martini
carbohydrate model, oligosaccharides such as amylose and
curdlan,31 and cellulose32,270 have also been parameterized.
Martini parameters for the important class of glyco-lipids were
developed as well,27 including biologically relevant lipids for
the thylakoid membrane, signalling lipids such as PI and its
phosphorylated analogues PIPn, as well as gangliosides. A
pioneering study on multi-component membranes containing
the ganglioside monosialotetrahexosylganglioside (GM1) shows
formation of GM1 enriched nano-domains that act as protein
shuttles between membrane regions with diﬀerent degrees
of order.127
Polymers
Coarse-graining has been of fundamental importance in the
field of polymer modelling. In order to study the large size of
polymer chains and the associated slow relaxation processes, a
reduction of the degrees of freedom has proven absolutely
necessary. Although the Martini model was designed primarily
with biomolecular applications in mind, there is no reason why
the same philosophy could not be extended to soft matter in
general. Indeed, there is a growing number of basic polymer
systems for which Martini parameters have been derived,
currently including polyethyleneglycol (PEG),33,271 polystyrene,34
triblock copolymers polyethyleneoxide–polypropyleneoxide–
polyethyleneoxide (PEO–PPO–PEO),223,272 polyurea,273 Nafion
ionomers,274 polyester coatings composed of two dicarboxylic
acids and a diol, esterified to neopentyl glycol monomers and
crosslinked by hexa(methoxymethyl)melamine,275 polymer
nanofibres composed of nylon-6 (polycaprolactam),276 PAMAM
dendrimers40,41,219 and PEG-conjugated PAMAM dendrimers,277
and amphipols.236 Two recent examples are illustrative of the
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type of applications for which the Martini model can be used.
Simulations of nanocoating of a polymer matrix composed of
polymethylmethacrylate (PMMA), by Uttarwar et al.,278 show the
effect of nanoparticle (NP) concentration, size, and polydispersity
on the behaviour of the polymer matrix. For instance, the
presence of NPs leads to elongation of the polymer chains as
the radius of gyration is increased (Fig. 8A). Simulations of grafted
polystyrene brushes in good solvent (benzene), by Rossi et al.,279
explore the structural and dynamical configuration of the
brushes as a function of their grafting density in a high grafting
density regime (0.1–0.3 chains nm2) (Fig. 8B). The presence of
metastable collapsed states, with free chain ends trapped close
to the substrate, is revealed at all grafting densities. These
collapsed states are shown to be long-lived, surviving over a
time scale of several microseconds.
Nanoparticles
The two-dimensional carbon sheet graphene and its three
dimensional cousins fullerene and carbon nanotubes (CNTs)
enjoy a huge scientific interest due to their interesting mechan-
ical and electrical properties, with many realised and potential
applications. The interaction of these nanoparticles with bio-
logical material is of specific importance with respect to their
toxicity. To address these concerns, a number of groups have
started developing Martini models for fullerene,37,39,280 gra-
phene,281,282 and CNTs,38,283–287 and explore how they interact
with lipids and surfactants. For instance, in a breakthrough
study by Wong-Ekkabut et al.,37 the lipid membrane was shown
to be a very good solvent for fullerenes (Fig. 9A). Clustering in
the aqueous phase, the fullerene aggregates spontaneously
enter the membrane and disperse on a microsecond time scale.
Likewise, as demonstrated in a pioneering study by Titov
et al.,281 graphene nanoflakes dissolve into a lipid membrane and
adopt a flat orientation in between the membrane leaflets (Fig. 9B).
The affinity of graphene-based particles for lipids is also
elegantly shown in a study by Wallace and Sansom38 on CNTs.
Dispersing lipids or surfactants randomly in the aqueous
solution, self-assembly of a CNT–lipid complex is observed
(Fig. 9C). In addition, the interaction of other nanoparticles
such as gold clusters,288–292 nanocrystals,293 and coated nano-
particles294,295 with lipid membranes has been studied using
Martini. As an example, in the work of Lin et al.,288 the interaction
of functionalized gold particles with DPPC/DPPG membranes was
systematically investigated, showing penetration, disruption, pore
formation or wrapping (Fig. 9D) depending on the surface charge
of both the nanoparticle and the membrane. In a related study,296
the aggregation of monolayer-protected gold nanoparticles in
various solvents was investigated. We expect many more of such
studies in the near future, for instance along the lines of a very
recent study of the effect of PEG functionalized phospholipids on
nanotube bundling297 and on morphological characterization
of polymer-functionalized gold nanoparticles.298 Finally, we
mention three other non-biological applications, namely nano-
pore inhibition,299,300 surface wetting,301 and physisorption of
organic molecules on graphite.302
Limitations of Martini
Martini, as any other model, has a number of limitations. It is
obviously important to know these limitations, both to make
sure the model is used appropriately and to further improve the
model. Some of Martini’s limitations are shared with coarse-
grained models at a fundamental level, such as the chemical
and spatial resolution, which are both limited compared to
atomistic models; a shifted balance between entropy and
Fig. 8 Polymeric systems. (A) Nanoparticle coated with PMMA resin278 (courtesy
Y. Huang). Nanoparticle is shown in grey, the polymer in blue. (B) Grafted
polystyrene chains in good solvent279 (courtesy G. Rossi). Support is shown in
yellow, polymer backbone in red with one polymer highlighted with blue phenyl
rings. Adapted with permission from ref. 278 and 279. Copyright (2012–2013)
American Chemical Society.
Fig. 9 Nanoparticles interacting with lipids. (A) Fullerene dissolved in a lipid
membrane37 (courtesy L. Monticelli), with fullerenes in red, lipid tails green, lipid
heads blue/orange. (B) Graphene sandwiched in between the bilayer leaflets281
(courtesy P. Kral), with graphene flake in orange, lipid tails blue, lipid heads green.
(C) Carbon nanotube wrapped by surfactants38 (courtesy M. S. P. Sansom), with
CNT in grey, surfactant heads red and tails blue. (D) Wrapping of a cationic gold
nanoparticle by a negatively charged lipid membrane288 (courtesy H. W. Zhang),
showing the cationic coat in red, the lipid tails in yellow, and lipid heads in purple.
Adapted with permission from ref. 38, 281 and 288. Copyright (2007–2011)
American Chemical Society.
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enthalpy due to the reduced number of degrees of freedom; and
kinetics that are modified in unpredictable ways. Other limita-
tions are more tightly linked to Martini itself and could be
improved in the future at the level of coarse-graining inherent
in Martini, or by accepting more detailed descriptions in parts
of the system of interest. This presents an interesting philoso-
phical problem, as the essence of a coarse-grained model is that
it contains less detail than a particular reference model (atomistic
models, in Martini’s case). While it is clear that adding back
details in such a model can improve its accuracy, this also negates
(some of) its computational advantages. Below we discuss a
number of known limitations of Martini.
Model resolution and accuracy
With its 4-1 mapping and its particular range of interactions,
Martini can reproduce the thermodynamics of a large number
of diﬀerent organic compounds. This mapping clearly limits
the chemical resolution. Phosphatidylcholine lipids can be
used to illustrate this in a biological context. Key properties
of such lipids, including melting temperature and bilayer
stability and thickness depend strongly on the length of
the acyl chains. The lipid dilauroylphosphatidylcholine (DLPC)
has two acyl chains with 12 carbon atoms, represented in
principle by 3 Martini beads, while the lipid dipalmitoyl-
phosphatidylcholine (DPPC) has two acyl chains with 16 carbon
atoms, represented by 4 Martini beads. The common lipid
dimyristoylphosphatidylcholine (DMPC) with 14 carbon atoms
falls somewhere in the middle. Thus the mapping to specific
lipids is not unique. Martini reproduces properties such as
lipid bilayer density profiles, but within the limitations of
this mapping and the spatial resolution aﬀorded by the size
of Martini particles. Similar limitations occur in common
biomolecules such as sterols, where small changes in ring
structure or tail can have large eﬀects on the thermodynamics
of membranes that contain these sterols; carbohydrates, where
stereochemistry and other details that are too subtle to easily
represent in a coarse-grained model occur; and proteins, where
all amino acids have a diﬀerent representation but it is unlikely
subtle diﬀerences between similar side chains are accurately
represented.
Martini in many cases is comparable in accuracy to atomistic
models, particularly in thermodynamics, but it also amplifies a
number of limitations in atomistic models, where lack of
electronic polarizability in the standard force field is one of
the main limitations. Important interactions such as cation–pi
interactions in proteins or the strong electrostatically driven
interactions between benzene molecules are difficult to include
in a coarse-grained force field to reproduce both the strength
of these interactions and, more challenging, the peculiar geo-
metries resulting from these interactions. However, the wide
use of Martini and extensive testing in the original papers
clearly shows the degree of agreement with experiments and
atomistic simulations and allows an assessment of whether
Martini is accurate enough for a particular application. Recent
progress in linking Martini more closely to atomistic simula-
tions through backmapping and through hybrid simulations
appears promising in terms of extending the use of Martini
simulations to problems that may be outside the current
resolution (see ‘Outlook’ section).
Eﬀective time scale
In atomistic simulations the time scale is well-defined and
properties such as water diﬀusion coeﬃcients are used to judge
the quality of the underlying model. In coarse-grained simula-
tions this is not normally the case. Coarse-graining involves
modifying the energy landscape to become smoother, which
eﬀectively results in more sampling of the energy landscape in
a given time period, speeding up the kinetics of the system.
This is one of the main advantages of coarse-grained models,
but the speed-up is not easily predictable and is not likely to be
the same for all degrees of freedom.303 In Martini the current
best estimate of a semi-universal factor of speed-up compared
to atomistic simulations is about 4, based on lateral diﬀusion
coeﬃcients of lipids13 and TM peptides130 in membranes.
Some papers therefore report an eﬀective simulation length,
which is 4 times the formal simulation length. However, the use
of a global speed-up factor has to be considered with care. In a
systematic study by de Jong304 on a range of compounds, speed-
up factors based on self-diﬀusion ranged between 1.2 and 22
comparing Martini to experiments and 0.79 and 17 comparing
Martini to atomistic simulations. The speed-up is dependent
on the type of molecule: Martini alkanes have a small speed-up
compared to experiments or even a reduced speed compared to
atomistic simulations, whereas alcohols show large speed-up
factors. This can be rationalized by the lack of explicit hydrogen
bonds in the CG model. Water, although highly polar, shows a
relatively small speed-up (E2.5), but this is due to the bundling
of four molecules together. Lipids show a large speed-up,
comparable to polar fluids suggesting that their diﬀusion is
mainly controlled by the polar head groups.
These estimates of speed-up factors are based on single-
molecule diﬀusion, but the underlying mechanism has not
been carefully investigated and may be diﬀerent for tracer
diﬀusion, viscosity, collective diﬀusion, etc. For instance, the
viscosity of standard Martini water has been determined78,305 at
Z = 7  104 Pa s (at 323 K) in close agreement with the
experimental value of 5.5  104 Pa s and actually closer to the
experimental value than the widely used SPC water model. For
lipid bilayers, apparent surface shear viscosity has been calcu-
lated by Baoukina et al.79 and is similar to experimental
estimates; for lipid monolayers, the apparent surface shear
viscosity was similar to previously reported atomistic simula-
tions but much smaller than measured experimentally for
monolayers.252 However, a direct comparison for surface
viscosities is diﬃcult because experimental shear rates are
much lower and simulation results are expected to depend on
the system size. Baoukina et al.103 also calculated the eﬀect of
the presence of domains on monolayer surface viscosity and
found a clear increase in viscosity in the presence of domains or
at higher compression levels, in qualitative agreement with
experiment. Thus although there is some data on viscosities,
more thorough investigations would be welcome. In addition,
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density fluctuations (collective diﬀusion) have not been care-
fully analyzed yet. Another example of comparing eﬀective time
scales is the recent study on the dynamics of the onset of phase
separation in membranes composed of ternary lipid mixtures.105
Comparing atomistic andMartini simulations, the authors conclude
that, while sharing the structural features of phase separation
in the CG model, the onset of demixing for the atomistic model
is 40 times slower.
In addition to the eﬀect of a simplified energy landscape,
there is also a much smaller source of uncertainty in kinetics
due to the choice of masses of the Martini particles. The actual
time step used in molecular dynamics depends on the masses
of the particles involved, which correspond to real atomic
masses in atomistic simulations but to eﬀective masses in
coarse-grained simulations. All Martini particles have a mass
of 72 amu for full particles or 45 amu for scaled particles,
regardless of the underlying atoms. Eﬀectively this scales the
simulation time diﬀerently for groups with diﬀerent underlying
masses. This could be corrected by using more accurate masses
but since the masses do not aﬀect the ensemble obtained from
a molecular dynamics simulation this is not critical. As atomistic
simulations increase in reach we expect more detailed compar-
isons of kinetics between atomistic and Martini simulations,
which would help calibrate the eﬀective timescale of Martini
simulations. One useful application of Martini is to assess the
amount of sampling required to study a particular phenomenon,
such as lipid mixing, before attempting this with atomistic
simulations.
Free energies, enthalpies, entropies
A third category of properties that are fundamentally aﬀected
in CG models are thermodynamic properties, particularly
the balance between enthalpy and entropy. Martini is para-
meterized to reproduce accurate free energies, with a reduced
number of degrees of freedom compared to atomistic simula-
tions. Reducing the number of degrees of freedom aﬀects the
entropy of the simulation system, which is compensated for by
reduced enthalpic terms in the model. However, this means
that the temperature dependence of coarse-grained models is a
priori not correct. It also means that although free energy
diﬀerences are accurate, a break-down of free energies into
enthalpies and entropies may not be accurate. The classical
example of this is the potential of the mean force (PMF)
between two hydrophobic molecules in solution. MacCallum
et al. performed detailed all-atom calculations of the PMF
between two hydrophobic helices, showing a deep well in the
free energy, despite an enthalpic barrier at a slighter higher
separation than the equilibrium conformation.306 Aggregation
was driven by a favorable entropy, related to the structure of
water around the hydrophobic helices and the release of water
trapped between the two helices at near-contact. Corres-
ponding Martini simulations with the standard water model
showed the right free energy profile, but the basis for this
profile is almost entirely enthalpic.307 The polarizable Martini
water model shows a bit more water-ordering eﬀects, but still
did not reproduce the atomistic simulations. The BMW water
model did at least reproduce the correct sign although the
features of the entropy/enthalpy decomposition still diﬀered
from the atomistic simulations. This water model is not a universal
solution due to its interactions with other parts of the Martini force
field, but does point out the importance of water structure if one
wants to reproduce more accurately the underlying thermo-
dynamics. A recent study compared atomistic simulations with a
diﬀerent CG model in their ability to reproduce diﬀerent compo-
nents of the thermodynamic driving force for a ligand binding to a
protein.308 The authors concluded that an anisotropic component
to the water model interactions combined with translational
entropy was suﬃcient to retain a reasonable enthalpy/entropy
balance and temperature dependence of ligand binding.
Thus in solution, PMF decompositions based on CG models
should be used with great caution and in many cases results
with both the standard and polarizable water models in Martini
will be unrealistic. In hydrophobic solvents or membranes, the
story may be diﬀerent as water ordering is probably one of the
least accurate components of Martini, while lipid ordering or
hydrophobic solvents are likely to be represented much more
accurately. PMFs for dimerization of two fullerene molecules in
octane gave good agreement between atomistic and coarse-
grained simulations, including decomposition in entropy and
enthalpy profiles (Monticelli, personal communication). A
study of the aggregation of two TM helices gave thermodynamic
parameters, including enthalpy and entropy, in reasonable
agreement with experiment,47 although obtaining these para-
meters from atomistic simulations is out of reach at the
moment. Thus it seems entropy/enthalpy decompositions in
apolar environments give at least qualitatively useful results
and warrant further testing.
In a number of studies, Baron et al. compared thermo-
dynamic properties of alkanes and lipids in atomistic and
coarse-grained simulations, including configurational entro-
pies of alkanes309 and lipids,310 as well as a larger range of
thermodynamic properties in liquid alkanes.18 In general, both
models showed similar behaviour, although the temperature
dependence of alkanes and lipids modelled with Martini was
notably weaker than with the atomistic force field or compared
to experiment.
Other properties related to strong water interactions and
water ordering are also challenging to reproduce in coarse-
grained models like Martini. Free energies of hydration and
transfer of groups with full charges are so large that they are
diﬃcult to fit in the range of interactions Martini is capable of
reproducing based on the current LJ and limited Coulomb
interactions. Charge–charge interactions in apolar solvents
are too weak because the implicit screening in Martini and
the size of the Martini particles reduce interactions too much.
One way to improve this may be to place charges off-centre to
allow a closer interaction, analogous to recent changes in the
protein force field.15
The functional form of the non-bonded potential
The use of a LJ 12-6 potential to describe the non-bonded
interactions in Martini is, in hindsight, not the best choice.
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The steep repulsion leads to overstructuring of fluids compared
to atomistic models, as evidenced for instance in the radial
distribution functions (RDFs) for simple alkanes.309 Further-
more, the LJ 12-6 potential has only a limited fluid range.
Consequently, Martini water is prone to freezing even at room
temperature, although the switch function reduces attraction
and increases the melting temperature compared to a pure LJ
function. The melting temperature of Martini water is 290 
5 K.13 In confined geometries freezing is more pronounced. A
practical, if chemically diﬃcult to justify, solution is the use of
‘anti-freeze’ particles, water particles with a slightly larger
radius.13 Switching to a diﬀerent non-bonded interaction
potential could, in principle, improve the relative stability of
the fluid phase (see ‘Outlook’ section). A related property that is
not accurate in current versions of Martini is the surface
tension of the air/water interface, which is much too low. This
results in unrealistic behaviour in monolayers at the air/water
interface, where lipids do not spread homogeneously at high
surface tensions but rather form pores in tighter packed
monolayers.250 It is also apparent in water/oil interfaces, which
show properties of consisting of two interfaces (water/air and
air/oil) close to each other, rather than a single interface.251
Using the polarizable water model,21 these properties improve
but only to a limited amount.
Secondary structure constraints
Realistic modelling of conformational changes in proteins
and peptides in biomolecular force fields is essential for
many problems, but is a major challenge in CG simulation.
Martini is unusual among CG protein force fields in that it has
rather sophisticated side chains but a very simple backbone,
consistent with the overall design philosophy of Martini.
However, that means that conformational changes with the
simplified description of Martini cannot be accurately repro-
duced in general. In the current version of the protein force
field, we apply secondary structure constraints to maintain
extended and helical secondary structures by strengthening
bonded interactions to maintain a preset secondary structure.
The secondary structure elements are able to move relative to
each other, which in general does not lead to accurate protein
structures in solution but enables a number of applications of
primarily TM proteins like MscL mentioned above. These
proteins are constrained by the membrane environment and
consist mainly of helices with short loops where details of the
conformations are in some cases not important. Situations
where proteins or peptides change structure considerably
cannot be reliably handled. A few examples that are hindered
by this but otherwise seem very suitable for Martini are
membrane-binding peptides that may be unstructured in
solution but adopt specific conformations when binding to
the membrane, and may adopt yet diﬀerent structures in
aggregates or channels; membrane-binding proteins with loops
that may fold into helices or unfold from a protected, perhaps
multimeric, structure into a membrane-binding state, and
other systems with similar types of conformational changes.
These changes can be incorporated as assumptions in Martini
simulations, of course, but this is typically less desirable.
Perhaps a combination of backmapping and coarse-graining
steps with atomistic and coarse-grained models may be useful
in some of these cases. Further work in this direction would be
interesting. In a more experimental approach, we tried to
include backbone pseudo-dihedral potentials that reproduce
backbone conformations of atomistic simulations.178 This
method enables some new applications but requires atomistic
simulations as input and is not generally transferable between
sequences or between chemical environments.
Testing the limits: simulations of pore formation
We discussed a range of limitations of Martini, most of which
have their origins clearly in the choice of approximations,
including the resolution of the model and the functional form
of the potential. However, Martini can also break down in cases
where there is no obvious reason. One example of this is pore
formation in lipid bilayers. This is a particularly interesting
example because lipid-lined pores occur in a wide range of
problems for which Martini has been used or could be used.
Pore formation, or more generally defects, in lipid bilayers
occur in processes such as permeabilization of bilayers by
antimicrobial peptides, transport of polar molecules across
membranes, fusion intermediates, and lipid flip–flop from
one membrane leaflet to another. These defects involve water
penetrating into the membrane, followed by rearrangements of
phospholipids. This is an interesting test case for Martini
because of the relatively small characteristic size at the level
of water molecules and the complex environment of water and
polar head groups in a low-dielectric membrane interior. We
have studied membrane defects in great detail by atomistic
simulations and tried to reproduce this data with Martini.311
Fig. 10A shows a snapshot of a DLPC bilayer in which we have
restrained a DLPC headgroup in the centre of the bilayer.
Atomistically this leads to pore formation and an extensive
structural defect, but with Martini (Fig. 10C) the structure is
very different although the free energy cost of placing the lipid
at the centre is similar. To test whether this is due to the simple
water model, we repeated the calculation with the polarizable
Martini water, but with the same result (Fig. 10B). To test
whether the difference is due to the large size of a Martini
water particle compared to an atomistic water molecule, we
tethered atomistic water molecules together in tightly-bound
groups of four, but this gave nearly the same results as the
regular atomistic simulations. Increasing the interaction
between water and headgroups did give structures closer to
the pore observed in atomistic simulations (Fig. 10D), but
worsened other important bilayer properties such as the area/
lipid. We will continue to use a system like this for tests of
future refinements of Martini.
Outlook
Given the large interest of the modelling community to use
Martini on the one hand, and the clear limitations of the model
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on the other hand, there is a lot of work to be done. Below we
sketch the main developments we foresee in the near future.
The next generation, Martini 3.x
The use of a LJ 12-6 potential to describe the non-bonded
interactions in Martini leads to overstructuring as discussed
above. To reproduce the ‘softness’ of real systems a smaller
power for the repulsive term appears more appropriate, as in the
recently reparameterized CG model of Klein and co-workers.312
The other drawback of the LJ 12-6 potential is the limited fluid
range. Possible solutions are given in the literature,313,314
including switching to a power 4 attraction or to a diﬀerent
potential such as the Morse potential. For the next generation
of the Martini force field, we aim to change the non-bonded
form to a softer potential with longer-ranged attraction. We
are currently exploring the use of the Mie potential,315 a
generalized LJ potential with exponents n and m. Preliminary
results304 indicate that key properties can be reproduced with
Mie 5-4, 5-3, 4-3, and 4-2 potentials in their shifted form.
Another major direction forward is the development of a
foldable protein backbone. The lack of structural flexibility of
the Martini proteins obviously limits the applicability range of
the model. While aiming at a CG model capable of folding a
protein from its sequence may be overly ambitious, describing
the backbone in a more realistic manner would be an important
improvement. One solution is the use of a specific set of bonded
parameters optimized to reproduce an ensemble obtained from
atomistic simulations or NMR experiments, an approach already
used to model amyloids178 and fusion peptides.91 For a less
biased approach, the directionality of H-bonds needs to be
restored. Available coarse-grained models for protein folding
represent the backbone H-bonding in quite diﬀerent manners
and generally use a specific potential.316–320 In contrast we want
to keep a simple and generic approach. For instance, we have
been exploring the possibility of using a fixed dipole to repre-
sent the backbone polarity, see Fig. 11. The dipoles interact
with other dipoles and particles through regular Coulomb
and LJ potentials. Importantly, this description restores the
directionality of backbone interactions, and has a number of
added benefits: the overall dipole along the axis of an a-helix
is represented, and the charges are natural sensors of the
dielectric environment. A similar approach was used to model
polar side chains more realistically in Martini 2.2 and may
prove to be an effective way to model polar chemical building
blocks in general.
More Martini molecules
Nucleotides, RNA and DNA, constitute the major class of
biomolecules that has not yet been thoroughly parameterized
for Martini. Although there is a Martini model available for a
small piece of DNA,321 a more generic approach is required to
make the model applicable to all nucleic acids. We are currently
developing parameters for single and double stranded DNA,
using a systematic approach analogous to our work on carbo-
hydrates.31 A preliminary model is shown in Fig. 1F. Another
class of biomolecules that requires careful parameterization
are glycans (oligosaccharides), e.g. peptidoglycans that are
the building block of the bacterial cell wall, or the glycans
attached to proteins in the process of glycosylation, or lipo-
polysaccharides that are the major component of the outer
membrane of Gram-negative bacteria. The Martini carbo-
hydrate31 and glycolipid27 force fields can serve as starting
points. Apart from biomolecules, other molecular systems are
in principle amenable to the Martini CG approach. We encourage
parameter development for many more polymers and nano-
particles, and expect a growing number of applications
Fig. 10 Snapshots of a DLPC phospholipid restrained at the centre of a DLPC
bilayer.311 Water is shown as red licorice, lipid tails as grey lines, restrained lipid as
thick grey lines, and headgroup phosphate (phosphorus) and choline (nitrogen)
as balls. (A) Atomistic, (B) polarizable Martini water, (C) standard Martini water,
(D) polarizable Martini water with increased attraction between water and lipid
headgroups. Reprinted with permission from ref. 311. Copyright (2011) American
Chemical Society.
Fig. 11 Toward a foldable Martini protein backbone (courtesy X. Periole). (A)
Stabilization of an a-helix due to added degrees of freedom in the form of
charged particles (red +q, blue q) attached to the backbone (green), mimicking
the CQO and N–H hydrogen acceptor and donors and providing an overall
dipole moment. (B) Zoomed view of the interaction of the peptide backbone
with the polarizable water model. Effective H-bonds along the backbone and
with the water particles are shown with dashed lines. (C) Close up of the
polarizable water model, consisting of a central LJ bead with two charged
particles attached, representing four real waters.
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involving hybrid molecules; combining bio- and synthetic
molecules into hybrid molecules is a booming research field
in the era of synthetic biology. And why not a Martini force field
for ionic liquids? Using polarized or polarizable CG particles
this might well turn out to be a fruitful approach. Attempts in
this direction have recently been undertaken.322
Algorithmic improvements aﬀecting Martini
A number of algorithmic developments are worthwhile to
mention as they are likely to improve the accuracy, speed,
and stability of Martini simulations in the near future. A first
issue is the choice of thermostat. Although Martini was devel-
oped with the widely-used Berendsen weak-coupling scheme
for temperature and pressure control, recent developments
promise eﬃcient temperature control methods that conserve
momentum,323 which may be important in future work on time
and length scales where hydrodynamic eﬀects play a role. It
remains to be seen how accurately the Martini model can
capture hydrodynamic eﬀects; the fact that the solvent viscosity
is actually reproduced quite well is promising in that respect
(see the discussion on the eﬀective time scale above). Second, to
improve speed, the buﬀered Verlet pairlist scheme recently
implemented in GROMACS shows promise. Instead of a switch
function, the Verlet scheme uses a straight cut-oﬀ in combi-
nation with a shift of the potential to zero at the cut-oﬀ.
Neighbour list searching is much faster with this method.
However, as this involves a change in the overall shape of the
non-bonded potential, it might aﬀect system properties. Pre-
liminary results (de Jong and Marrink, unpublished) show that
key properties of the Martini model remain unaﬀected when
using a slightly reduced cut-oﬀ (1.1 nm instead of the current
1.2 nm) in combination with an optimized neighbour list cut-oﬀ.
These settings result in a speed-up of almost 100%. Third,
improving numerical stability is also deemed important,
especially in light of high-throughput applications (see below).
One common reason for Martini simulations to crash is that
dihedrals, formed by four particles, are not defined when three of
these particles are co-linear. In atomistic models this does not
occur but at the coarser level of Martini this is diﬃcult to avoid.
We are working on alternative definitions of local geometry to
avoid this numerical problem, making use of combined bending-
torsion potentials or dummy-assisted dihedrals.324
Mixing Martinis
One of the current challenges in biomolecular simulation is to
develop eﬀective multi-scale methods,325–329 which combine
the advantages of atomistic and coarse-grained models. Multi-
resolution methods can either use a static division as in QM/MM
(denoted ‘‘hybrid’’ models), or allow particles to change resolu-
tion on the fly (‘‘adaptive’’ models). Recently we introduced a
straightforward scheme to perform hybrid simulations, making
use of virtual sites to couple the two levels of resolution.327 With
the help of these virtual sites interactions between molecules at
different levels of resolution, i.e. between CG and atomistic
molecules, are treated in the same way as the pure CG–CG
interactions. As a proof of principle, hybrid GROMOS/Martini
simulations of simple liquids like butane and small peptides
were shown to behave well. However, in an extension of this
work330 challenges are pointed out in regard to the electrostatic
coupling between the two levels of resolution. In particular, a
proper description of the interaction between polar AA mole-
cules suffers from the poor short range screening behaviour of
the CG solvent. Applications of this multi-scale method dealing
with less polar solvents, e.g. a lipid bilayer, are more promising.
For instance, the gating of AA mechanosensitive channels in
CG bilayers is currently being studied by our group (Fig. 12A).
To achieve a quantitatively more accurate method, cross optimiza-
tion of the interactions between theMartini and the atomistic force
field is probably necessary, as has been recently attempted in
the PACE force field.331
A breakthrough implementation of an adaptive multi-scale
method is the AdResS (Adaptive Resolution Simulation)
approach, developed by Kremer and co-workers.332 In this
method, a transition region allows molecules to pass from
atomistic to CG resolution and vice versa as a function of the
position of the molecule in the simulation box. The coupling of
resolutions is achieved through the use of a thermodynamic
force in the transition region that compensates for the
chemical potential diﬀerence between the two resolutions.
We are currently exploring the coupling of Martini to atomistic
resolution using the AdResS scheme (Fig. 12B). Within the field
of biomolecules, Martini based multi-scale methods appear
ideally suited to study e.g. protein–ligand binding, where the
active site and ligand are modelled in atomistic detail and the
rest of the protein together with the solvent is coarse-grained,
or aggregation of membrane proteins where the surface of the
proteins is treated at a finer grained level compared to the
interior and lipids may increase their resolution in close
contact with proteins. Another potentially powerful approach
to multi-scale simulations is based on Hamiltonian Replica
Exchange MD (HREMD). In HREMD, multiple simulations are run
at the same time with systematic differences in the Hamiltonian, in
this case the atomistic and CG Hamiltonians. Coupling of CG
models to AA models using REMD has been pioneered by
several groups,333,334 but has not yet been used in combination
with the Martini model. Not really multi-scale, but worth
mentioning as an interesting method that opens a range of
Fig. 12 Mixing Martini and AA force fields. (A) Hybrid simulation of an atomistic
membrane protein, MscL, in CG environment330 (courtesy H. Ingolfsson). Protein
channel depicted in red, lipid bilayer with cyan tails and blue/ochre heads, and
water beads purple. (B) Adaptive resolution simulation of CG Martini and
atomistic water using the AdResS scheme (courtesy M. de Melo). The right hand
side shows CG water beads, the left hand side shows bundled clusters of four
atomistic SPC water molecules.
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new problems that can be studied, is the use of constant pH
algorithms with Martini.335
At the other end of the scale, there is promise in combining
Martini with self-consistent field theory,336 to couple Martini to
multi-domain elastic network models,337,338 and to combine
Martini with protein–protein docking approaches. Another
scale bridging opportunity is the ability of Martini to yield
converged PMFs between proteins.169 These PMFs may subse-
quently be used to describe the effective interactions between
simplified proteins in a solvent free approach, a method
coined Atomistic Resolution Brownian Dynamics (ARBD).339
In a related line of research, we are currently parameterizing
a variant of the Martini force field that is solvent free
(‘‘Martini dry’’).
Automated high throughput
World-wide the trend remains to invest in massively parallel
computing with petaflop clusters currently topping the list of
the fastest computers (see http://www.top500.org). Within the
foreseeable future, the exascale will be reached, with clusters
composed of millions of cores. Even local facilities will
approach the petascale soon. This opens the way to simulations
of either very huge systems or massively high throughput. The
largest systems simulated with Martini to date include systems
of a few million particles, e.g. a huge membrane patch from
which a tether was pulled (cf. Fig. 2A), totalling almost 4 000 000
particles in a box with dimensions 86  86  65 nm3 and
simulated for 1 ms;79 a lipid nanoparticle for gene delivery
(cf. Fig. 6A) with 1 400 000 particles in total, a box size of
54  54  54 nm3 and simulated for 10 ms;229 and a tetrameric
row of F1F0 ATPase dimers (cf. Fig. 3A) composed of 4 635 000
particles in a box of 84  336  19 nm3 and simulated for
100 ns.148 Examples of high throughput studies are: scoring of
the aggregation propensity of all 400 dipeptides based on 400 
100 ns simulations of a box of 300 solvated dipeptides;172
construction of a CG database for the positioning of 91
membrane proteins in a lipid bilayer, based on hundreds of
self-assembly simulations;119 and performing 10000 separate
simulations by using the Folding@Home distributed computing
project to model membrane fusion.239 A recent example of high-
throughput simulations is the systematic sampling of protein–
protein interfaces (Fig. 13). In the forthcoming exascale era, and
with the aid of the continuous improvement of simulation
software, we can expect system sizes to grow to 109 particles,
timescale reaching seconds, and high throughput studies sys-
tematically exploring 1000 s of conditions. To harvest this
enormous power, automated workflows should be designed
and optimized. Efforts in that direction are already undertaken
in a number of groups, for example in the grid-enabled web
portal for MD simulations,340 automated topology builder341 and
automatic embedding of membrane proteins.342 To facilitate the
Martini workflow, we have developed the Martinize script15
which generates GROMACS topology files for proteins from
coordinate input files. We are currently developing scripts to
automatically perform and analyse simulations of heterogeneous
membranes composed of arbitrary lipids and proteins.
Conclusions
In the ten years since its initial publication, the Martini model has
developed from amodel for simulations of lipids and surfactants to
the most widely-used coarse-grained force field for biomolecular
simulation and increasingly in synthetic biology. It has been used
in a broad range of applications and been subjected to many
critical tests, resulting both in exciting scientific results and clear
routes towards further development.
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